Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (38 ops.)
Latest filing published 03 Sept 2026 for Fulgent Genetics, Inc., €36k. Read the official filing
Filing timeline
BuySaleJian Xie
Insider track record
Disclosed buys
0
Disclosed sells
38
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Jian Xie: trading record in brief
Jian Xie (senior executive) discloses dealings in Fulgent Genetics, Inc. to SEC (Form 4). The record holds 91 filings, for trades running from 1 May 2021 to 2 September 2026.
The open-market record consists of 38 sales worth €2.4M, with no purchase. The rest of the record consists of 53 share grants. 2026 to date brings no purchases and 3 sales.
The record was last updated on 3 September 2026 with an open-market sale (€36k) in Fulgent Genetics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jian Xie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations91 total
25 of 91 declarations
